What Christina Applegate's Story Can Help Us Understand About Breast Cancer and Genetic Risk

Her account, in her own words

In October 2008, CNN published Christina Applegate's account of the previous six months, given in an interview for Oprah.com.

She said her mother had had breast cancer, and that she had been having regular mammograms since she was 30. In 2007, she said, her doctor told her mammograms were not enough for her, because her breasts were dense, and suggested an MRI.

That MRI, she said, found something. A biopsy followed, and a week later the result came back positive. She was 36. She said doctors told her the cancer was only in her left breast and that it had been caught at an early stage. She had a lumpectomy within a week, along with a biopsy of her lymph nodes, and was told she would need six weeks of radiation rather than chemotherapy.

Then a test for the BRCA gene came back positive. She said that changed the calculation, because radiation treated what was there without addressing the chance of a new cancer later. She chose a bilateral mastectomy, which she had in July 2008.

That is what she chose to make public. This page adds nothing about her subtype, her care since, or her health now.

Why density changes the plan

A mammogram is an x-ray of the breast. NCI's fact sheet describes what it involves: the breast is placed between two plates and compressed, and several images are taken from different angles.

Dense breast tissue matters because of how it looks on that x-ray. Dense tissue appears white. So does a tumor. Fatty tissue appears dark, which makes a white spot easy to see. In a dense breast the contrast largely disappears, and a cancer can hide in plain sight.

That is why some people at higher risk are offered MRI alongside mammography. MRI does not rely on that contrast. It is more sensitive, and it also flags more findings that turn out to be nothing, which is why it is used for people at higher risk rather than everyone. Our overview of mammograms explains what the report says and what a callback means.

What a BRCA result actually says

BRCA1 and BRCA2 are ordinary genes that everyone has. Their normal job is repairing damaged DNA. A harmful change in one of them leaves cells less able to make that repair, and over a lifetime that raises the risk of breast and ovarian cancer, among others.

Three points from NCI's fact sheet are worth holding onto.

A harmful variant can be inherited from either parent, not only from the mother's side. It is passed on independently of sex, so a father can carry it and pass it to a daughter without any breast cancer appearing in the family for a generation.

A positive result is a risk figure, not a diagnosis and not a certainty. Some carriers never develop cancer.

And a negative result does not clear anyone. Most breast cancer occurs in people with no inherited variant at all, which is why screening does not stop for someone who tests negative.

NCI recommends genetic counseling before and after testing, because what a result means depends on family history, on which variant was found, and on what a person wants to do next. BRCA gene changes walks through the options.

When to get checked

See a clinician about any of these, whatever your age:

• A new lump or firm area in the breast or armpit that does not come and go with your cycle.
• A change in the shape or size of one breast.
• Skin that dimples, puckers, or thickens like orange peel.
• A nipple that turns inward when it did not before, or a rash or crusting on the nipple.
• Discharge from one nipple, especially if it is bloody and happens without squeezing.
• Redness, warmth, and swelling of a breast that does not settle with antibiotics.

Separately, ask your clinician whether your family history changes when your screening should start. A first-degree relative diagnosed young, several relatives with breast or ovarian cancer, or breast cancer in a male relative are the patterns that most often prompt a referral to genetic counseling.

What the numbers describe

For 2026 the American Cancer Society projects about 321,910 new female breast cancers in the United States and about 42,140 deaths; SEER reprints that projection. The median age at diagnosis is 64, which is why a diagnosis at 36 draws attention — it is uncommon, not unheard of.

About 64% of cases are found while still confined to the breast, and five-year relative survival for that group is 100.0% — meaning survival in that group matches the general population of the same age. It is 87.5% once the cancer has reached nearby lymph nodes, and 33.8% once it has spread to distant sites. Across all stages it is 91.9%. NCI draws all four from women diagnosed between 2016 and 2022.

These are averages across an enormous group diagnosed years ago, before some current treatments existed. They describe a population. They are not a statement about any one person.

What this does not mean

Applegate's choice of a bilateral mastectomy followed a positive genetic test and her own weighing of the options. It is not the recommended response to a breast cancer diagnosis in general, and for most people it does not improve survival compared with breast-conserving surgery and radiation.

Nor does her story mean everyone should ask for an MRI. Added imaging is offered on the basis of risk, and for people at average risk it produces more false alarms than it prevents harm.

And "caught early" is her account of what she was told, not a category anyone can apply from the outside. Stage comes from pathology and imaging, and the plan follows from receptor status and node involvement as much as from size. Our guide to breast cancer explains what those terms mean on a report.

Sources

• CNN (Oprah.com): Christina Applegate — Why I had a double mastectomy
• NCI: BRCA Gene Changes — Cancer Risk and Genetic Testing Fact Sheet
• NCI: Mammograms Fact Sheet
• NCI SEER Cancer Stat Facts: Female Breast Cancer

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.